Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.

Slides:



Advertisements
Similar presentations
Idiopathic Thrombocytopenic Purpura
Advertisements

Approach to child with purpura
Heather D. Mannuel, MD, MBA March 12, 2008
1 Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
PLATELET DISORDERS Joanna Rupa-Matysek.
Normocytic Anemia Dr. Fatin Al-Sayes, MD, MSc, MRCPath Consultant Hematology / Assistant Professor King Abdulaziz University Hospital.
Platelet count.
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
Bleeding disorders Doc. MUDr. L. Boudová, Ph.D.. Bleeding disorders I. Vessels - increased fragility II. Platelets - deficiency or dysfunction III.Coagulation.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
NEOPLASTIC DISORDERS OF THE BONE MARROW
Acute leukemia Mohammed Al-matrafi.
PLATELETS. PLETELET PHYSIOLOGY Platelets Production: Hematopoietic stem cell  Megakaryoblast  Megakaryocyte  Fragmentation of cytoplasm Platelets.
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
KANUPRIYA CHATURVEDI 1.  1. Explain the relationship between platelet count and bleeding risk.  2. State the underlying pathologic mechanisms that may.
DISORDERS OF PRIMARY HEMOSTASIS
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Bleeding and coagulation disorders
IMMUNE THROMBOCYTOPENIA Cathy Payne MSN, ACNP-BC Hematology/Oncology Nurse Practitioner Ironwood Cancer and Research Centers.
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
Polycythemia Group C: Melanie, Michele, Sarah.
Myeloproliferative Disorders (Neoplasm)II Dr. Ibrahim. A. Adam.
PLATELETS AND HEMOSTASIS
Chemotherapy/ Biotherapy for Hematology Disease Processes.
ITP Immune (Idiopathic) Thrombocytopenic Purpura AM Report 5/25/2010.
MLAB C OAGULATION K ERI B ROPHY -M ARTINEZ Coagulation Disorders: Primary Hemostasis.
Dr.Leni Lismayanti, SpPK Dept of Clinical Pathology RSHS/FKUP Bandung
HEMOSTASis Nada Mohamed Ahmed , MD, MT (ASCP)i.
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
November 23, Idiopathic Throbocytopenic Purpura.
Mrs. Mahdia Samaha Alkony. Haemostatic mechanisms  The bleeding vessel constricts  Platelets aggregate at the site, forming an unstable hemostatic plug.
Bleeding Disorders Dr. Farjah H.AlGahtani
Splenectomy in Hematologic Disorders
Quantitative and qualitative platelet disorders
MLAB Hematology Keri Brophy-Martinez Unit 23: CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
APLASTIC ANEMIA.
Bleeding Disorders JANUARY 19, 2012 Erin M. Kwolek.
Myeloproliferative Disorders (MPD) concepts Neoplastic (clonal) disorders of hemopoietic stem cells Over-production of all cell lines, with usually one.
Laboratory Management. ITP is suspected in patients with isolated thrombocytopenia Because manifestations of ITP are nonspecific, other causes of isolated.
Hemorrhagic diatheses in children. Gastrointestinal bleedings. Sakharova I. Ye., MD, PhD.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Idiopathic Thrombocytopenic Purpura Clinical Features.
Hemostatic process 1- Vascular Consrriction 2- Platelet plug formation 3- Fibrin formation ( Coagulation ) 4- Fibrinolysis.
1 CASE REPORT hematology Monika Csóka MD, PhD year old boy no abnormalities in previous anamnesis 2 weeks before viral infection (fever, coughing)
Hematology Block: Overview and Advice Tim Boswell, M4 Presentation created on 3/21/16.
CBC Basic Interpretation Tanim I. Aziz, MBBS. CBC… is one of the most common laboratory tests in medicine. Typically, it includes the following: White.
Nursing Management: Hematologic Problems Chapter 31 Overview Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Thrombocytopenia Chapter 31 Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Coagulation tests CBC- complete blood count
Abnormal bleeding in children J Kiwanuka. GENERAL INTRODUCTION.
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
APLASTIC AND HYPOPLASTIC ANEMIAS Waggas Elaas. APLASTIC ANEMIA Aplastic anemia is a severe, life threatening syndrome in which production of erythrocytes,
Chapter 22. Bleeding trait and disorders O bleeding trait: spontaneous bleeding, bruising, purpura O cause: vessel defect, platelet defect, coagulation.
THROMBOCYTOPENIA Reduction in platelet count below 150 x 109
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Bleeding disorders due to vascular & platelets abnormalities
Disseminated Intravascular Coagulation
Chapter 13 Lesson 13.2 anemia Aplastic anemia Hemolytic anemia Pernicious anemia sickle cell thalassemia Hemochromatosis polycythemia vera Hemophilia purpura.
Chapter 18 Disorders of Hemostasis
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
Anemia By: Dr Sunita Mittal.
MLAB 1415-Hematology Keri Brophy-Martinez
Platelets disorders.
Approach to Thrombocytopenia
The Fascinating World of Haemostasis and Thrombosis
IMMUNE THROMBOCYTOPENIC PURPURA MBBSPPT.COM
Immune thrombocytopenic purpura (ITP)
Presentation transcript:

Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets –disc-shape cells –arise from megakariocytes in bone marrow –1/3 of platelets are sequestrated in the spleen –other 2/3 circulate for 7-10 days –are responsible for primary hemostasis –normal platelet count : G/l

Bleeding Diathesis Is caused by inherited or acquired defects of –vessel wall –platelets number and/or function –coagulation system Is charcterised by –spontaneous bleeding –extensive bleeding after minimal trauma

Platelets Disorder Disorder of platelet number –thrombocytopenia –thrombocytosis Disorder of platelet function

Disorder of platelets function defects of platelet adhesion –inherited: vonWillebrandt’s disease, Bernard-Soulier syndrome –acquired: uremia defects of platelet aggregation –inherited: Glantzmann’s thrombasthenia –acquired: dysproteinemia, drug ingestion (ticlopidin) defects of platelet release –inherited: grey-platelet, Hermansky-Pudlak,Chediac-Higashi syndr. –acquired: cardiopulmonary bypass, myeloproliferative disorders, drugs

Thrombocytosis Thrombocytosis resulting from myeloproliferation –essential thrombocythemia –polycythemia vera –chronic myelogenous leukemia –myeloid metaplasia Secondary (reactive) thrombocytosis –systemic inflammation –malignancy –iron deficiency –hemorrhage –postsplenectomy

Thrombocytopenia (1) Decreased marrow production of megakariocytes congenital disorders –thrombocytopenia with absent radii (TAR) –Fanconi’s anemia –May-Hegglin anomaly acquired disorders –marrow infiltration with malignant cells –marrow fibrosis –aplastic and hypoplastic anemias ( idiopathic, drugs, toxins ) –deficiency states ( vitamin B12, folate, iron ) –paroxysmal nocturnal hemoglobinuria

Thrombocytopenia (2) Splenic sequestration of circulating platelets splenic enlargement due to tumor infiltration splenic enlargement due to portal hypertension

Thrombocytopenia (3) Increased destruction of circulating platelets congenital disorder –Wiscott-Aldrich syndrome, Bernard-Soulier syndrome acquired disorders nonimmune destruction –vascular prostheses, cardiac valves –DIC –hemolytic-uremic syndrome/thrombotic thrombocytopenic purpura –sepsis immune destruction –idiopathic thrombocytopenic purpura ( ITP ) acute and chronic –drug-induced thrombocytopenia –chronic autoimmune disorders –infection (HIV) –malignancies

Platelets Disorder - signs and symptoms asymptomatic if platelets count > 50 G/l onset of bleeding after trauma - immediate site of bleeding - superficial: skin, mucous membranes, nose, genitourinary tract physical finding - petechiae, ecchymoses

Idiopathic Thrombocytopenic Purpura (1) the most common cause of isolated thrombocytopenia autoimmune disease with antiplatelet antibodies and shortened platelets life span forms of ITP acute ITP –children (90% of pediatric case of immune thrombocytopenia) – preceded by viral infection –spontaneous recovery within 4-6 weeks in 60% of patients chronic ITP –20-40 years –women predominance F:M=3:1

Idiopathic Thrombocytopenic Purpura (2) Clinical features –petechiae –ecchymoses –mucose membranes bleeding –menorrhagia –rare internal, intracranial bleeding Diagnosis –platelet count <100G/l –bleeding time - usually normal –peripheral blood smear - large platelets –bone marrow examination - normal or increased number of megakariocytes –antibodies against Gp IIb/IIIa –shortened platelet survival

Treatment of ITP not necessary unless platelets count > 20G/l or there is extensive bleeding corticosteroids permanent responses - 30% –prednisone 1mg/kg for 4-6 weeks splenectomypermanent responses - 60% immunosuppresive drugs intravenous immunoglobulins other - danazol, antiRhD